medigraphic.com
ISSN 1029-3035 (Electronic)

2015, Number 2

<< Back Next >>

Mediciego 2015; 21 (2)

Prognostic value of echocardiography in patients with dilated cardiomyopathy

Artigas PR, Hernández ML, Porbén CN, Guerra PMO

Language: Spanish
References: 22
Page: 27-35
PDF size: 107.12 Kb.


ABSTRACT

Introduction: in dilated cardiomyopathy the beta-blocker therapy produces favorable functional effects through changes in the expression of genes that regulate myocardial contractility and pathological hypertrophy. Objective: to evaluate the prognosis of patients with dilated cardiomyopathy treated with β-blockers by a set of parameters obtained in the initial echocardiographic examination in the outpatient adult Cardiology of “Dr. Antonio Luaces Iraola” Universitary Hospital of Ciego de Ávila. Method: an evaluation study of technologies and services was carried out during September 2011 to September 2013. The study group consisted of 37 patients. It was worked with the whole universe and all patients met the inclusion criteria. Results: males and ages ranging from 41 years onwards in both sexes were the predominant. A statistically significant relationship between the majority of analyzed echocardiographic variables was existed with the improvement in ventricular function and diastolic diameters of the left ventricular in patients although it was noted that the initial value of the ejection fraction of the left ventricular was not associated with this improvement (p›0,05). The initial degree of diastolic dysfunction had statistical relationship (p‹0,05) with clinical and echocardiographic improvement. Conclusions: Prognostic models created showed good validity index, positive and negative predictive value for each and every analyzed variables.


REFERENCES

  1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden W, et al. Heart disease and stroke statistics—2012 update a report from the American heart association. Circulation [Internet]. 2012 [citado 12 Mar 2014];125(1):e2-e220. Disponible en: https://circ.ahajournal s.org/content/125/1/e2.full

  2. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet [Internet]. 2010 [citado 12 Abr 2014];375(9716):752-62. Disponible en: http://www.researchgate.net/profile/John_Jefferies/ publication/41621614_Dilated_cardiomyopathy/links/0912f50a7a23e6722f000000.pdf

  3. Elliott PM. Classification of cardiomyopathies: evolution or revolution?. J Am College Cardiol [Internet]. 2013 [citado 12 Mar 2014];62(22):2073-4. Disponible en: http://content.onlinejacc.org/data/Journals/JAC/929399/10008.pdf

  4. Hare JM, Braunwald E. Miocardiopatía dilatada, restrictiva e infiltrante. En: Braunwald E, Zipes DP, Bonow RO, Libby P, editores. Tratado de Cardiología. Madrid: Elsevier; 2013. p. 1583- 602.

  5. Grupo CTO. Cardiología y Cirugía Cardiovascular. En: Grupo CTO. Manual de Medicina y Cirugía, 8va ed. [Internet]. 2011 [citado 12 Abr 2014]. Disponible en: http://www.grupocto.es/web/medicina/ar/pdf/ME_UltraR2011_8ed_CapMuestra.pdf

  6. González García A, Pérez Barquero MM, Formiga F, González Juanatey JR, Quesada MA, Epelde F, et al. ¿Se ha incrementado el uso de bloqueadores beta en pacientes con insuficiencia cardíaca en medicina interna? Implicaciones pronósticas: registro RICA. Rev Esp Cardiol [Internet]. 2014 [citado 12 Abr 2014];67(3):196-202. Disponible en: http://www.revespcardiol.org/es/se-ha-incrementado-el-uso/avance-resumen/S0300-8932(1 3)00403-X/

  7. Hernández RJ, Valiente MJ, Pila PR. Caracterización tisular en paciente con Miocardiopatía Dilatada: Evaluación no invasiva de la fibrosis, predicción de la respuesta a la terapia con beta bloqueadores. Anal Cir Cardíaca Vascular. 2005;11(3):140-6.

  8. McMurray J, Petne J, Murdoch D, Kline F. Clinical epidemiology of heart failure: public and private hearth burden. EUR Heart J. 1998;19(suppl):9-16.

  9. Ivano Scandurra R, García-Altés A, Nebot M. Impacto social del consumo abusivo de alcohol en el estado español. Consumo, coste y políticas. Rev Esp Salud Pública. 2011; 85:141-7.

  10. Pereira Nunes MC, Barbosa MM, Ribeiro AL. Factores predictivos de la mortalidad en pacientes con miocardiopatía dilatada: importancia de la enfermedad de Chagas como etiología. Rev Esp Cardiol. 2010;63(7):788-97.

  11. Ferreira F, Galrinho A, Soares R, Branco L, Abreu J, Feliciano J, et al. O volume da aurícula esquerda como marcador ecocardiográfico de prognóstico em doentes com miocardiopatia dilatada. Rev Portuguesa Cardiol [Internet]. 2013 [citado 12 Mar 2014];32(11):865-72. Disponible en: http://www.sciencedirect.com/science/article/pii/S0870255113001571

  12. Torres Macho J, García De Casasola G, Conthe Gutiérrez P. Ecocardiografía clínica básica en Medicina Interna. Rev Clínica Esp [Internet]. 2012 [citado 12 Mar 2014]; 212(3):141-6. Disponible en: http://www.researchgate.net/profile/Gonzalo_Garcia_Casasola/publication/251 558737_Ecocardiografa_clnica_bsica_en_medicina_interna/links/00b495242619d3e2ec00000 0.pdf

  13. Mc Murray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. European Heart J. 2012;33:1787–847.

  14. Mosterd A, De Bruijne M, Hose A. Osefulness of echocardiography in detecting left ventricular dysfunction in population based studies (The Rotterdam Study). Am J Cardiol. 1997;79:103- 4.

  15. Nunes MCP et al. Valor prognóstico da disfunção diastólica em pacientes com miocardiopatia dilatada chagásica. Rev Bras Ecocardiografia. 2004;17(4):15-22.

  16. Kamel CS, Siqueira-Filho AG, Barreto LFM, Benchimol M. Insuficiência cardíaca congestiva. Correlação entre a classe funcional e as funções sistólica e diastólica avaliadas pela ecocardiografia com Doppler. Arq Bras Cardiol. 2001;76:127-31.

  17. Pinamonti B, Lenarda AD, Sinagra G, Camerini F. Restrictive left ventricular filling pattern in dilated cardiomyopathy assessed by doppler echocardiography: clinical, echocardiography and hemodynamic correlations and prognostic implications. J Am Coll Cardiol. 1993;22:808-15.

  18. Ito T, Suwa M, Otake Y, Moriguchi A, Hirota Y, Kawamura K. Left ventricular Doppler filling pattern in dilated cardiomyopathy: relation to hemodynamics and left atrial function. J Am Soc Echocardiogr. 1997;10;18-25.

  19. Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 1994;24:132-9.

  20. Shen WF, Tribouilloy C, Rey JL, Baudhuin JJ, Boey S, Dufosse H et al. Prognostic significance of doppler-derived left ventricular diastolic filling variables in dilated cardiomyopathy. Am Heart J. 1992;124:1524-33.

  21. Acquatella H, Carrasco HJ, Nessi AJ, Londono JC, Rodríguez AE, Moleiro F, Mendoza I. Molecular Epidemiology of Chagas disease in Venezuela. SOJ Microbiol Infect Dis [Internet]. 2013 [citado 12 Mar 2014];1(1):6.dx.doi.org/10.15226/sojmid.2013.00101 Disponible en: http://symbiosisonlinepublishing.com/microbiology-infectiousdiseases/microbiology-infectious diseases01.pdf

  22. Freedland KE, Carney RM, Rich MW. Impact of depression on prognosis in heart failure. Heart Failure Clinics [Internet]. 2011 [citado 12 Mar 2014];7(1):11-21. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032411/




2020     |     www.medigraphic.com